Biobased PE Colorants and Compounds for Medical and Pharma Applications
Avient has expanded its line of medical-grade Mevopur materials for pharmaceutical packaging and medical devices.
Two new additions to the Mevopur line of medical-grade materials from Avient Corp. are aimed at helping producers of pharmaceutical packaging and medical devices more easily reach sustainability goals. Mevopur medical-grade materials are produced according to ISO13485-2016 protocols and supported by testing to ISO 10993-1, USP, European Pharmacopeia and ICH Q3D guidelines.
▪ There are now new Mevopur color and additive masterbatches based on a PE carrier that is manufactured using non-fossil feedstocks. The resins have biobased content up to 95%, as calculated to ASTM D6866 standard. As drop-in replacements for fossil-based color concentrates, they can be processed the same way and recycled in the same recycling channels as conventional fossil-based polyolefins.
▪ There are also new Mevopur pre-colored compounded formulations based on bio-derived PE for customers who prefer ready-to-use solutions.
Related Content
-
Why Are They Blending Biopolymers?
A sit-down with bioplastic producer Danimer Scientific showed me there are more possible answers to that question than I had previously thought.
-
BASF Highlighting How They 'Make, Use and Recycle Future Solutions'
NPE2024: BASF is using its proprietary computer-aided engineering tool Ultrasim when designing for sustainability in a broad range of industries.
-
Best Practices for Purging PHA and PHA/PLA Blends
Because bioplastics are processed at lower temperatures, purging between jobs requires a different process and purging agents than those applied for traditional resins.
